Phenotyping cardiomyopathy in adult zebrafish

Alexey V Dvornikov1, Pieter P de Tombe2, Xiaolei Xu1

  • 1Department of Biochemistry and Molecular Biology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Insights

Zebrafish models offer new ways to study human cardiomyopathies like hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Better phenotyping tools are crucial for distinguishing these heart conditions in zebrafish.

Area of Science:

  • Cardiovascular Research
  • Zebrafish Models
  • Human Disease Modeling

Background:

  • Hypertrophic cardiomyopathy (HCM) involves increased myofilament Ca2+ sensitivity, excessive contractility, and impaired relaxation.
  • Dilated cardiomyopathy (DCM) is characterized by insufficient sarcomere contractility and reduced cardiac pump function, leading to heart failure.
  • Zebrafish are increasingly used as a model organism for human cardiomyopathies due to their suitability for high-throughput screening.

Purpose of the Study:

  • To review existing cardiomyopathy models in adult zebrafish.
  • To discuss available morphologic and functional phenotyping methods for zebrafish hearts.
  • To summarize the current understanding of HCM and DCM in adult zebrafish.

Main Methods:

  • Review of existing literature on zebrafish cardiomyopathy models.
  • Analysis of morphologic and functional phenotyping techniques.
  • Synthesis of current knowledge on HCM and DCM in zebrafish.

Main Results:

  • Zebrafish models facilitate the discovery of novel genetic factors for cardiomyopathies.
  • High-throughput screening in zebrafish aids in developing new therapeutic strategies.
  • Improved phenotyping tools are necessary to differentiate between HCM and DCM in small zebrafish hearts.

Conclusions:

  • Zebrafish represent a valuable model for studying human cardiomyopathies.
  • Further development of phenotyping methods is essential for precise diagnosis of cardiomyopathy subtypes in zebrafish.
  • This review provides a foundation for future research in zebrafish-based cardiomyopathy studies.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
575
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
509
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
575
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
462
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
613
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
360